Insider · CIK 0001201254

COLLIER EARL M JR

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001201254

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-02-27	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−750 sh	—	—	0
2025-02-27	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+750 sh	$1.39	+$1,042.5	57,606
2025-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,240 sh	—	—	3,240
2025-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+11.9K sh	—	—	11,940
2025-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+5,750 sh	—	—	5,750
2024-04-23	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+30K sh	$1.39	+$41.7K	56,856
2024-04-23	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−30K sh	—	—	53,000
2024-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+29.3K sh	—	—	29,250
2024-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+14.3K sh	—	—	14,280
2024-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+8,030 sh	—	—	8,030
2023-10-10	CAPRCAPRICOR THERAPEUTICS, INC.P Purchase	Director	PPurchase	+10K sh	$2.83	+$28.3K	26,856
2023-02-14	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,401 sh	$1.39	+$1,947.39	16,856
2023-02-14	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,401 sh	—	—	0
2023-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+11.9K sh	—	—	11,870
2023-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+19K sh	—	—	19,000
2023-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+37.8K sh	—	—	37,770
2022-03-08	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−15.5K sh	—	—	0
2022-03-08	CAPRCAPRICOR THERAPEUTICS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+15.5K sh	$1.39	+$21.5K	15,455
2022-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+63.1K sh	—	—	63,060
2021-01-04	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+72K sh	—	—	71,951
2020-06-05	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+83K sh	—	—	83,000
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−750 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−1,401 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+2,856 sh	—	—	2,856
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15.5K sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−4,750 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+1,401 sh	—	—	1,401
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,437 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+15.5K sh	—	—	15,455
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+2,437 sh	—	—	2,437
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+3,050 sh	—	—	3,050
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,050 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+4,750 sh	—	—	4,750
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,856 sh	—	—	0
2020-02-12	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (Right to Buy)A Award	Director	AAward	+750 sh	—	—	750
2019-08-08	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+4,750 sh	—	—	4,750
2019-01-22	TESARO, Inc.Director Restricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−4,052 sh	—	—	0
2019-01-22	TESARO, Inc.Director Nonqualified Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−25K sh	—	—	0
2019-01-22	TESARO, Inc.Director Nonqualified Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2019-01-22	TESARO, Inc.U Disposition from Tender	Director	UDisposition from Tender	−2,090 sh	$75.00	−$157K	0
2019-01-22	TESARO, Inc.Director Nonqualified Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2019-01-22	TESARO, Inc.Director Nonqualified Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12K sh	—	—	0
2019-01-22	TESARO, Inc.Director Nonqualified Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−7,209 sh	—	—	0
2018-06-01	TESARO, Inc.Director Restricted Stock UnitsA Award	Director	AAward	+4,052 sh	—	—	4,052
2018-06-01	TESARO, Inc.Director Nonqualified Stock Option (right to buy)A Award	Director	AAward	+7,209 sh	—	—	7,209
2018-06-01	TESARO, Inc.A Award	Director	AAward	+1,631 sh	—	—	2,090
2018-01-02	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+30.5K sh	—	—	30,500
2017-06-01	TESARO, Inc.Director Nonqualified Stock Option (right to buy)A Award	Director	AAward	+12K sh	—	—	12,000
2017-06-01	TESARO, Inc.A Award	Director	AAward	+459 sh	—	—	459
2017-01-03	CAPRCAPRICOR THERAPEUTICS, INC. · Stock Option (right to buy)A Award	Director	AAward	+28.6K sh	—	—	28,560

Recent filings

Accepted (ET)
Feb 284
COLLIER EARL M JR0001415889-25-006069
SEC(opens sec.gov)
Jan 64
COLLIER EARL M JR0001415889-25-000868
SEC(opens sec.gov)
Apr 254
COLLIER EARL M JR0001415889-24-011488
SEC(opens sec.gov)
Jan 44
COLLIER EARL M JR0001415889-24-000652
SEC(opens sec.gov)
Oct 124
COLLIER EARL M JR0001415889-23-014099
SEC(opens sec.gov)
Feb 154
COLLIER EARL M JR0001415889-23-002649
SEC(opens sec.gov)
Jan 54
COLLIER EARL M JR0001415889-23-000593
SEC(opens sec.gov)
Mar 94
COLLIER EARL M JR0001415889-22-002812
SEC(opens sec.gov)
Jan 44
COLLIER EARL M JR0001415889-22-000278
SEC(opens sec.gov)
Jan 64
COLLIER EARL M JR0001104659-21-001584
SEC(opens sec.gov)

Companies

Address

GENZYME CORPORATION 500 KENDALL STREET

CAMBRIDGE, MA, 02142